All content on this site is intended for healthcare professionals only. By acknowledging this message and accessing the information on this website you are confirming that you are a Healthcare Professional.
The GvHD Hub uses cookies on this website. They help us give you the best online experience. By continuing to use our website without changing your cookie settings, you agree to our use of cookies in accordance with our updated Cookie Policy
How can we use microbial-derived metabolites to prevent GvHD?
Featured
During the 47th Annual Meeting of the European Society for Blood and Marrow Transplantation (EBMT), the GvHD Hub spoke to Erik Thiele Orberg, Technical University of Munich, Munich, DE. We asked, How can we use microbial-derived metabolites to prevent GvHD?
How can we use microbial-derived metabolites to prevent GvHD?
Microbial-derived metabolites are small, easily synthesized molecules that may offer the same benefits as fecal microbiota transplant, without concerns for transmitting infectious diseases, like COVID-19. Orberg envisions that metabolites could be administered prophylactically to patients undergoing stem cell transplantation.
Related articles
Newsletter
Subscribe to get the best content related to GvHD delivered to your inbox